This AstraZeneca Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday

Comments
Loading...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Considering buying AZN stock? Here’s what analysts think:

Read More:

AZN Logo
AZNAstraZeneca PLC
$66.94-0.16%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
45.84
Growth
97.28
Quality
46.78
Value
19.44
Price Trend
Short
Medium
Long
Got Questions? Ask
Which analysts will drive Equinor to new highs?
How will AeroVironment's upgrade impact defense sector stocks?
What does Energizer's upgrade mean for consumer goods investments?
Is AstraZeneca a buy signal for pharmaceutical stocks?
Which companies could benefit from Chewy's upgraded outlook?
How might the healthcare sector react to AstraZeneca's rating change?
What are the implications of Chewy's price target increase for e-commerce stocks?
Which energy companies might follow Equinor in upgrading?
Could analyst upgrades signal a market shift in stocks?
How will these upgrades affect investor sentiment in tech stocks?
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Posted In: